ATP5A1 antibody
Quick Overview for ATP5A1 antibody (ABIN6137324)
Target
See all ATP5A1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human, Mouse (Murine), Rat (Rattus)
-
Immunogen
- Recombinant Protein
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Storage
- -20 °C
-
-
-
: "Polyacetylene glycoside attenuates ischemic kidney injury by co-inhibiting inflammation, mitochondria dysfunction and lipotoxicity." in: Life sciences, Vol. 204, pp. 55-64, (2018) (PubMed).
: "GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis." in: PLoS ONE, Vol. 13, Issue 3, pp. e0193473, (2018) (PubMed).
-
: "Polyacetylene glycoside attenuates ischemic kidney injury by co-inhibiting inflammation, mitochondria dysfunction and lipotoxicity." in: Life sciences, Vol. 204, pp. 55-64, (2018) (PubMed).
-
- ATP5A1 (ATP Synthase, H+ Transporting, Mitochondrial F1 Complex, alpha Subunit 1, Cardiac Muscle (ATP5A1))
-
Alternative Name
- ATP5A1
-
Molecular Weight
- 59kDa
-
Gene ID
- 498
-
UniProt
- P25705
-
Pathways
- Proton Transport, Ribonucleoside Biosynthetic Process
Target
-